Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efavirenz 600mg vs 800mg with Rifampicin in TB/HIV
NCT00533390Phase 4Terminated
- Sponsor
- Fundação Oswaldo Cruz
- Start
- Jan 2007
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of efavirenz in human immunodeficiency virus infection (HIV), sponsored by Fundação Oswaldo Cruz. Started Jan 2007; status: terminated.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00533390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00533390.